0.9930USD+4.31%Mkt Cap: 30.69M USDP/E: —Last update: 2026-06-01
Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company's…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap30.69M USD
Enterprise Value41.79M USD
Revenue (TTM)38.00K USD
Gross Profit-37.55M USD
Net Income (TTM)-61.44M USD
Revenue/Share0.0010 USD
Last Price0.9930 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees39
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.00
PEG—
EV/EBITDA-0.81
EV/Revenue1099.82
P/S779.93
P/B5.26
EPS (TTM)-1.46
EPS (Forward)-0.95
52W Range
0.77007% of range3.884
52W High3.884 USD
52W Low0.7700 USD
Profitability
Gross Margin0.00%
Oper. Margin-71362.50%
EBITDA Margin0.00%
Profit Margin-279263.64%
ROE-1099.27%
ROA-119.94%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-43.44M USD
CapEx (TTM)196.00K USD
FCF Margin—
FCF Yield—
Net Debt12.16M USD
Net Debt/EBITDA-0.24
Balance Sheet
Debt/Equity5.17
Current Ratio—
Quick Ratio—
Book Value/Sh0.1810 USD
Cash/Share0.5370 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJul 18, 2024
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)11.25 USD
Target Range6.000 USD – 15.00 USD
# Analysts4
Ownership
Shares Out.31.14M
Float14.43M
Insiders47.91%
Institutions18.50%
Short Interest
Short Ratio2.6d
Short % Float3.73%
Short % Out.2.08%
Shares Short648.53K
Short (prev mo.)652.27K
Technical
SMA 500.9518 (+4.3%)
SMA 2001.307 (-24.0%)
Beta2.10
S&P 52W Chg27.70%
Avg Vol (30d)218.00K
Avg Vol (10d)203.30K
Technical Indicators
RSI (14)47.3
MACD0.0017
MACD Signal0.0034
MACD Hist.-0.0016
BB Upper1.050 USD
BB Middle0.9789 USD
BB Lower0.9083 USD
BB Width14.44%
ATR (14)0.0704 USD
Vol Ratio (20d)0.66x